SWK Holdings Corporation (SWKH)
$16.05
Rating:
Recommendation:
-
| Symbol | SWKH |
|---|---|
| Price | $16.05 |
| Beta | 0.297 |
| Volume Avg. | 0.01M |
| Market Cap | 200.675M |
| Shares () | - |
| 52 Week Range | 15.26-19.99 |
| 1y Target Est | - |
| DCF Unlevered | SWKH DCF -> | |
|---|---|---|
| DCF Levered | SWKH LDCF -> | |
| ROE | 5.74% | Neutral |
| ROA | 5.03% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 7.93% | Neutral |
| P/E | 12.94 | Strong Buy |
| P/B | 0.73 | Buy |
Latest SWKH news
About
Download (Excel)SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.